ClinicalTrials.gg
CompletedNCT06749275SDF-RCLUpdated Dec 27, 2024

High Fluoride and Root Caries in Older Adults (NIT-RCL-UTALCA)

An interventional study of 5,000 ppm fluoride toothpaste and 22,600 ppm fluoride varnish in Root Caries, Cognitive Impairment and Fluor, sponsored by University of Talca. Completed at 1 site in Chile. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-12-27.

Sponsored by University of Talca · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 8 months after the study started (first participant enrolled Apr 2021, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
179
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This project aims to provide an effective solution for root caries lesions (RCLs), specifically in older persons with cognitive impairment through a non-invasive therapy with Silver Diamine Fluoride (SDF). We hypothesize that, due to its remineralizing potential and the cariostatic effect conferred by silver, 38% SDF (biannually applied) will be more effective than 5,000 ppm fluoride toothpastes or 22,600 ppm fluoride varnish in preventing and arresting RCLs in older adults with cognitive impairment. The aim of this project, therefore, is to compare the effectiveness of 38% SDF with high-fluoride toothpaste of 5,000 ppm and 5% fluoride varnish of 22,600 ppm, on the incidence and inactivation of RCLs in older adults with mild cognitive impairment.

A double-blind randomized controlled clinical trial (RCT) will be conducted. One hundred thirty-two 65-year-old or older participants diagnosed as having mild cognitive impairment will be invited to participate. To be eligible, subjects must have at least 5 teeth and 1 active RCLs. Participating older adults with moderate or severe cognitive impairment, dementia, severe dependency, terminal illness, aggressive behavior and alcoholism, will be excluded from the study. Included subjects will be randomly assigned to one of the 3 following study arms (n=44 per group):

  • Group 1 (Control): Toothbrushing twice per day with 5,000 ppm fluoride toothpaste
  • Group 2: Applications of 5% fluoride varnish (22,600 ppm) every 3 months + toothbrushing twice per day with 1,450 ppm fluoride toothpaste.
  • Group 3: Biannual applications of 38% SDF solution + toothbrushing twice per day with 1,450 ppm fluoride toothpaste.

Incidence and lesion inactivation (arrest) using Nyvad's criteria for RCLs will be the primary outcomes to assess the effectiveness of the treatments. Clinical assessment every 6 months up to 2 years will be carried out. RCL incidence and Relative Risk (RR) will be obtained and compared among the treatment groups.

This project will contribute novel scientific evidence on the effectiveness of SDF as a non-invasive therapy for RCLs with special focus on the increasing elderly population with cognitive impairment. The results of this project can be readily translated into dental practice to provide an effective and low-cost non-invasive tool to treat RCLs in cognitive impaired population, with potential implications in public health.

Read the detailed description

This project aims to provide an effective solution for RCLs, specifically in older persons with cognitive impairment through a non-invasive therapy with SDF. SDF has a cariostatic effect - unlike any other fluoridated product -, does not require patient compliance, only needs one annual or biannual application, is easy to manipulate even at home care and is a low-cost product. Root caries is a highly prevalent oral health problem in the elderly population, and it is estimated to increase significantly over time, particularly in people with cognitive impairment. Therapies intended for RCLs have been mostly restorative and highly heterogeneous. Furthermore, clinical management of RCLs, especially in subjects with cognitive impairment, is challenging for the clinician. Limited evidence supports the non-invasive treatment of RCLs, some of them with SDF. In people with cognitive impairment, however, no evidence has been reported, but this approach could be the most advantageous for this complex population. Thus, SDF for RCLs management in this population appears as a novel and attractive solution to the problem. The present study corresponds to a blind randomized controlled clinical trial (RCT) according to the CONSORT (Consolidated Statement of Reporting Trials) statement (Moher et al. 2012), with 3 parallel groups. The total sample (132 individuals) will be divided randomly into 3 groups (44 per group) by means of a listing and using the online software http://www.random.org/ following a simple 1: 1: 1 assignment procedure in each group, prepared by a researcher without clinical participation in the RCT, in order to keep clinical researchers blind. This person will also be responsible for recruiting patients and assigning them to the appropriate group.

The participants of this study will belong to a day center located in Talca, Chile, focused in providing care to people over 65 years of age or older, with cognitive impairment.

Sample size: The sample size was determined for the ANOVA test of repeated measurements using G* Power. The a priori analysis considered an average effect size (ie, 0.3), a 5% error, a statistical power of 80% and a correlation between the initial and final measurements of 0.8, considering a 30% loss rate, according to a previous study (Tan et al. 2010). This calculation gives a total sample of 132 individuals, which would correspond to 44 participants per group.

Intervention and clinical examination: Participants will be randomly assigned to one of the three treatment groups:

  • Group 1 or Control: Toothbrushing twice per day with 5,000 ppm fluoride toothpaste + individualized Oral Hygiene Instruction (OHI).

Toothpaste of 5,000 ppm of fluoride are considered as the control, since according to national (MINSAL 2015) and international clinical guidelines (Slayton et al. 2018) it would be the treatment of choice to treat RCLs, when there is strict compliance. Toothbrushing twice per day for two minutes, after breakfast and before bedtime. To increase F concentration and retention, participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea. This protocol is based on previous studies (León et al. 2019).

  • Group 2: Applications of 5% fluoride varnish (22,600 ppm) every 3 months + toothbrushing twice per day with 1,450 ppm fluoride toothpaste + individualized OHI.

The indication for the use of 1,450 ppm fluoride toothpaste is according to the same protocol indicated above (León et al. 2019), for group 2 and 3. In the case of group 2, the application protocol of 5% fluoride varnish will be used every 3 months, as recommended by experts for vulnerable older population (Gluzman et al. 2013).

  • Group 3: Biannual applications of 38% SDF solution + toothbrushing twice per day with 1,450 ppm fluoride toothpaste + individualized OHI.

The biannual application of the 38% SDF will be on all exposed root surfaces with RCLs. The teeth to be treated will be relatively isolated with cotton rolls or gauze, the surface to be treated will be dried with air and the SDF will be applied with a microbrush for 1 minute and then rinsed with water (Horst et al. 2017).

For the three groups the IHO will be individualized for each case, that is, according to the motor conditions of the patient or caregiver, or the conditions of oral access of the patient, basically focusing on an effective manual brushing according to previous studies (León et al. 2019; Tan et al. 2010).

Each participant will be evaluated at the center, where there will have access to fluoridated drinking water and a comfortable place, with good lighting (natural light and LED headlight) to make the initial diagnosis through an oral exam, where the RCLs will be registered. In addition, the team of researchers will have a portable dental equipment to facilitate the use of triple syringe with air and water, plus the use of ejector which will facilitate the intervention to the group with SDF. Prior to diagnosis, along with the participant and caregiver, the Comprehensive Oral Geriatric Assessment (COGA or VOGI in Spanish) form will be filled out, containing 4 items (Annex 1): sociodemographic information, systemic condition, oral health history and oral health exam. The filling time by the researcher of the COGA file, plus the total duration of the procedure, should not exceed 30 minutes. In cases where there is accumulation of bacterial plaque or calculus that makes clinical evaluation difficult, a previous supragingival scaling with or without root planning will be performed with manual instruments (curettes and jackets) and subsequently the diagnosis of RCLs will be made.

Fluoridated products and the different concentrations of toothpastes will be camouflaged and labeled by a member of the research team that does not participate in the clinical study who will keep them in separate boxes prior to delivery. The follow-up and evaluation of the outcomes will be carried out at the baseline and after 2 years. Oral and written instructions about the protocol for treatment with toothpastes will be given to participants and their caregivers. Additional toothbrushes and toothpastes will be provided to the volunteers every three months and adherence to treatment will be checked by returning the used dentifrices and toothbrushes to the investigators.

02

Conditions studied

  • Root Caries
  • Cognitive Impairment
  • Fluor
03

In context

Root Caries

39 studies on the registry are indexed under Root Caries; 14 are open to participants now.

This study's enrollment of 179 is above the median of 62 across 35 interventional studies indexed under Root Caries.

Browse Root Caries studies →

Lead sponsor

University of Talca is the lead sponsor of 16 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People 65 years of age or older, with regular attendance at the Amancay day center at least once a week or belonging to the subsample with mild cognitive impairment of the MAUCO cohort.
  • Medical diagnosis of mild cognitive impairment previously made by the psychiatrist of the Amancay team or by the MAUCO study and based on the diagnostic criteria of the International Association of Psychogeriatrics (Levy 1994).
  • Have at least 5 teeth in the mouth and 1 active RCLs, according to the methodology of previous studies (León et al. 2019; Tan et al. 2010).
  • To be able to do the toothbrushing yourself or, if you cannot do it, allow the person in charge to do it.

Exclusion criteria

Exclusion Criteria:

  • Severe dependent older adults and terminal patients (determined according to information from the Amancay team or by the MAUCO study).
  • Aggressive older adults (who present aggressive or risky attitudes towards a member of the research team during visits).
  • Alcoholic older adults (determined according to information from the Amancay team or by the MAUCO study).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
179 participants (actual)

Study arms

  • Active comparator
    5,000 ppm fluoride toothpaste

    Toothbrushing twice per day with 5,000 ppm fluoride toothpaste + individualized Oral Hygiene Instruction (OHI). Toothpaste of 5,000 ppm of fluoride are considered as the control, since according to international clinical guidelines (Slayton et al. 2018) it would be the treatment of choice to treat RCLs.

    Device: 5,000 ppm fluoride toothpaste

  • Experimental
    22,600 ppm fluoride varnish

    Applications of 5% fluoride varnish (22,600 ppm) every 3 months + toothbrushing twice per day with 1,450 ppm fluoride toothpaste + individualized OHI.

    Device: 22,600 ppm fluoride varnish

  • Experimental
    38% SDF

    Biannual applications of 38% SDF solution + toothbrushing twice per day with 1,450 ppm fluoride toothpaste + individualized OHI.

    Device: 38% SDF

Interventions

  • Device5,000 ppm fluoride toothpaste

    In group 1, toothbrushing with toothpaste of 5,000 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.

    Also known as: Caristop 5,000 ppm

  • Device22,600 ppm fluoride varnish

    The application protocol of 5% fluoride varnish will be used together with the 1,450 ppm paste with the same protocol of the group 1: toothbrushing with toothpaste of 1.450 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.

    Also known as: Duraphat 22.600 ppm

  • Device38% SDF

    The application protocol of 38% SDF annually will be used together with the 1,450 ppm paste with the same protocol of the group 2: toothbrushing with toothpaste of 1.450 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.

    Also known as: Fagamin 44,800 ppm

06

What researchers measure

Primary outcomes

  1. Root caries

    Activity status of root caries lesions will be clinically assessed

    Time frame: at 6, 12, 18 and 24 months

07

Study locations

1 site
  • Faculty of Dentistry
    Talca, Maule 3460000, Chile
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2021 to primary completion in Oct 2023, 30 months.

Of 21 interventional studies with no phase under Root Caries, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 55. This study's 30 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2024
First posted
Dec 27, 2024
StartActual
Apr 12, 2021
Primary completionActual
Oct 31, 2023
CompletionActual
Oct 31, 2023
Last update
Dec 27, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06749275
Lead sponsor
University of Talca
Responsible party
Soraya León Araya (Associate Professor, University of Talca) — Principal investigator
First posted
Dec 27, 2024
Start date
Apr 12, 2021
Primary completion
Oct 31, 2023
Completion
Oct 31, 2023
Last update
Dec 27, 2024

Study contacts

Soraya León Araya, PhD
principal investigator · University of Talca

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion